...in the news

Displaying 91 - 100 of 279 (10 per page)

Score	HS	BSN	CLB	EQT	IPO	M&A	IP	Date
								Feb 11, 2013
AMRI Signs Agreement for Exclusive License of its Tubulin Inhibitor Program for Cancer
								Jun 12, 2014
TSRL, Inc. Announces Agreement with Software Licensee
								Mar 14, 2013
Wearable Sensing Licenses Exclusive Rights to Commercialize QUASAR's Technology.
								Jun 16, 2014
Neogen Corporation Signs Exclusive Licensing Agreement with Senestech, Inc
								Jan 2, 2013
Microbiotix Announces Exclusive Worldwide Licensing Agreement for HCV NS5B Non-Nucleoside Polymerase Inhibitors
								Jan 30, 2015
*Astellas Pharma and Immunomic Therapeutics Announce Exclusive License for JRC2-LAMP-vaxTM, a Vaccine for Japanese Red Cedar Pollinosis**
								Sep 30, 2013
Insight Genetics Inks Deal with St. Jude Children's Hospital to Improve Donor Matching in Bone Marrow Patients
								Dec 4, 2013
Melior Licenses Novel Diabetes Drug to Bukwang Pharmaceutical Co
								Apr 23, 2014
Tolero Pharmaceuticals Receives FDA Orphan Drug Designation for Alvocidib for the Treatment of Acute Myeloid Leukemia
								Oct 7, 2014
FDA Grants Orphan Drug Designation to Dnatrix's DNX-2401 for the Treatment of Malignant Glioma